| |
98,00%
| Gesundheit |
| |
1,40%
| Nichtzyklischer Konsum |
| |
14,90%
| AstraZeneca plc |
| |
13,96%
| ROCHE HOLDING PAR AG |
| |
12,99%
| Novartis AG |
| |
8,21%
| NOVO NORDISK CLASS B |
| |
5,88%
| Sanofi SA |
| |
5,82%
| EssilorLuxottica SA |
| |
5,01%
| GSK Glaxo Smith Kline plc |
| |
2,88%
| Argenx |
| |
2,50%
| Lonza Group AG |
| |
2,29%
| Haleon plc |
| |
36,15%
| Schweiz |
| |
23,40%
| Großbritannien |
| |
13,36%
| Frankreich |
| |
12,04%
| Dänemark |
| |
6,16%
| Deutschland |
| |
4,95%
| Belgien |
| |
1,14%
| Niederlande |
| |
1,06%
| Schweden |
| |
0,54%
| Italien |
